Back to Search
Start Over
Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia
- Source :
- Antimicrobial Agents and Chemotherapy
- Publication Year :
- 2018
- Publisher :
- American Society for Microbiology, 2018.
-
Abstract
- Whole-genome sequencing was used to examine a persistent Enterococcus faecium bacteremia that acquired heteroresistance to three antibiotics in response to prolonged multidrug therapy. A comparison of the complete genomes before and after each change revealed the emergence of known resistance determinants for vancomycin and linezolid and suggested that a novel mutation in fabF , encoding a fatty acid synthase, was responsible for daptomycin nonsusceptibility. Plasmid recombination contributed to the progressive loss of vancomycin resistance after withdrawal of the drug.
- Subjects :
- Male
0301 basic medicine
E. faecium
VRE
medicine.drug_class
daptomycin
vancomycin
Enterococcus faecium
030106 microbiology
Antibiotics
Bacteremia
Microbial Sensitivity Tests
Microbiology
03 medical and health sciences
chemistry.chemical_compound
Mechanisms of Resistance
Drug Resistance, Multiple, Bacterial
Humans
Medicine
Pharmacology (medical)
heteroresistance
Aged
Pharmacology
biology
business.industry
Plasmid recombination
Linezolid
fabF
Vancomycin Resistance
biochemical phenomena, metabolism, and nutrition
biology.organism_classification
medicine.disease
3. Good health
Infectious Diseases
chemistry
Vancomycin
Drug Therapy, Combination
Daptomycin
business
Novel mutation
medicine.drug
Subjects
Details
- ISSN :
- 10986596 and 00664804
- Volume :
- 62
- Database :
- OpenAIRE
- Journal :
- Antimicrobial Agents and Chemotherapy
- Accession number :
- edsair.doi.dedup.....2d2562f67ab16d7ed052c6c113484c55
- Full Text :
- https://doi.org/10.1128/aac.02007-17